4//SEC Filing
BIOTECHNOLOGY DEVELOPMENT FUND II LP 4
Accession 0001019687-10-000265
CIK 0001282393other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:37 PM ET
Size
7.3 KB
Accession
0001019687-10-000265
Insider Transaction Report
Form 4
BIOTECHNOLOGY DEVELOPMENT FUND II LP
10% Owner
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−420,054$2,315,380→ 2,558,713 total(indirect: By Biotechnology Development Fund II, L.P.)
BIOASIA MANGEMENT LLC
10% Owner
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−420,054$2,315,380→ 2,558,713 total(indirect: By Biotechnology Development Fund II, L.P.)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The reported securities are owned directly by Biotechnology Development Fund II, L.P. and indirectly by BioAsia Management, LLC, as general partner of Biotechnology Development Fund II, L.P. BioAsia Management, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
Documents
Issuer
BIOFORM MEDICAL INC
CIK 0001282393
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001227253
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 8:37 PM ET
- Size
- 7.3 KB